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In this study a novel method to determine iodine concentrations in human breast milk 27 
was developed and validated. The iodine was analyzed by inductively coupled plasma 28 
mass spectrometry (ICPMS) following tetramethylammonium hydroxide (TMAH) 29 
extraction at 90
o
C in disposable polypropylene tubes. While similar approaches have 30 
been used previously, this method adopted a shorter extraction time (1 hour vs. 3 hours) 31 
and used Antimony (Sb) as the internal standard, which exhibited greater stability in 32 
breast milk and milk powder matrices compared to Tellurium (Te). Method validation 33 
included: defining iodine linearity up to 200µg L
-1
; confirming recovery of iodine from 34 
NIST 1549 milk powder. A recovery of 94 – 98 % was also achieved for the NIST 1549 35 
milk powder and human breast milk samples spiked with sodium iodide and thyroxine 36 
(T4) solutions. The method quantitation limit (MQL) for human breast milk was 1.6 µg 37 
L
-1
. The intra – assay and inter – assay coefficient of variation for the breast milk 38 
samples and NIST powder were <1% and <3.5% respectively. NIST 1549 milk powder, 39 
human breast milk samples and calibration standards spiked with the internal standard 40 
were all stable for at least 2.5 months after extraction. The results of the validation 41 
process confirmed that this newly developed method provides greater accuracy and 42 
precision in the assessment of iodine concentrations in human breast milk than previous 43 
methods and therefore offers a more reliable approach for assessing iodine 44 







INTRODUCTION  50 
Iodine is a major constituent of thyroid hormones, and an adequate supply of iodine 51 
before birth and in early infancy is essential for achieving optimal physical growth and 52 
mental development [1]. Breast milk is the sole source of iodine for exclusively breast-53 
fed infants, and it is therefore critical to ensure that the iodine content of the breast milk 54 
is sufficient to meet the nutritional needs of this infant population. However, relatively 55 
few studies have reported breast milk iodine concentrations, and this is largely due to 56 
the lack of a robustly validated method for assessing iodine concentrations in human 57 
breast milk.  58 
Since breast milk is a complex matrix, consisting of a range of bioactive components 59 
and nutrients, existing studies which have measured iodine concentrations in breast milk 60 
have applied comparable methods to those used for assessing iodine content of food. A 61 
number of analytical methods have been used for the determination of iodine in 62 
foodstuffs including the classic Sandell and Kolthoff kinetic – catalytic method [2,3], 63 
ion chromatography [4,5], inductively coupled plasma mass spectrometry (ICPMS) [6-64 
9], flame atomic absorbance spectrometry [10], high performance liquid 65 
chromatography [11] and ion – specific electrodes [9,11]. Of these methods, ICPMS is 66 
considered to be the gold standard, due to its high level of accuracy, precision and low 67 
detection limit, and is the most widely used approach for iodine quantification in foods. 68 
Moreover, ICPMS analysis following extraction by TMAH has been adopted by the 69 
European Committee for Standardization as the official method for the quantification of 70 
iodine concentrations in foodstuffs (EN 15111:2007) [12].  71 
However, while the ICPMS method is routinely used for the assessment of iodine in 72 
foods [9,13-17] , its suitability for the assessment of iodine in human breast milk has not 73 
been systematically assessed, and various aspects of the method have not been 74 
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optimized. It is not clear, for example, whether TMAH is a strong enough digesting 75 
agent to liberate iodine from T4 in breast milk or whether the internal standard used in 76 
the assay is suitable for the human milk matrix. In addition, the limit of determination of 77 
the previously reported method is relatively high (30 µg kg
-1
) [13], raising concerns 78 
about its sensitivity, and the extent of carryover between samples has not been 79 
thoroughly tested. The process of preparing the milk samples for analysis, in particular 80 
the procedure for homogenization of milk samples after thawing, has also not been 81 
clearly described.  82 
Therefore, the aim of this study was to modify existing approaches for assessing iodine 83 
concentrations in breast milk to address these method – related issues and thereby 84 
develop an ICPMS method which was suitable for the accurate and reproducible 85 
determination of iodine in human breast milk.  86 
 87 
 MATERIALS AND METHODS 88 
Reagents and Equipment 89 
Two human milk samples were collected in 50 mL polypropylene (PP) tubes with screw 90 
caps (Cat no. 227261, Greiner Bio – One GmbH, Frickenhausen, Germany) and frozen 91 
at -20
0
C until analysis for concentration, long term stability and spiked recovery.  92 
Certified reference material (CRM) produced by the National Institute of Standard and 93 
Technology (NIST), NIST 1549 non – fat milk powder (Maryland, USA) with a 94 
certified iodine level of 3.38 ± 0.02 mg kg
-1
 was used to assess the accuracy of iodine 95 
determination. 96 
Reagents for milk digestion included: high purity TMAH powder (Cat. No. T7505-97 
100G) from Sigma – Aldrich (New South Wales, Australia), a commercial stock iodine 98 
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standard (1000 mg L
-1
) from Australia Chemical Reagents (Queensland, Australia), two 99 
internal standard stock solutions, 1000 ± 3 mg L
-1
 Tellurium (Te) in 2% HNO3 + 0.2% 100 
HF and 1000 ± 3 mg L
-1
 Antimony (Sb) in 5% HNO3 + 0.1% HF from High – Purity 101 
Standards (South Carolina, USA). L – Thyroxine (T4) powder (Cat. No. T2376-1G) for 102 
recover tests was purchased from Sigma – Aldrich (New South Wales, Australia). 103 
High purity water generated by a Sartorius Water Purification System (Sartorius Stedim 104 
Australia Pty. Ltd., Dandenong South Victoria, Australia) was used for the preparation 105 
of all reagents, standards and samples. 106 
Graduated 50 mL PP digestion tubes with screw caps (Cat. No. SC475, Environmental 107 
Express South Carolina, USA) were used for digestion/extraction with TMAH. 108 
Graduated 15 mL PP tubes with screw caps (Cat. No. 188261 Greiner Bio – One 109 
GmbH, Frickenhausen, Germany) purchased from Interpath Services Pty Ltd (South 110 
Australia, Australia) were used as the analysis tube for the ICPMS. 111 
Millex HV disposable syringe filters (33 mm diam. 0.45 μm pore size; Millipore Corp, 112 
MA, USA) and Terumo 10 mL syringes (Binan Laguna, Philippines) were used to filter 113 
the digested breast milk samples.   114 
An IKA T25 digital Ultra Turrax homogenizer (IKA Ltd, Germany) was used to 115 
macerate breast milk samples before analysis. 116 
The digestion step was performed in a 54 well HotBlock
TM
 heating block with digital 117 
temperature control (Environmental Express Cat. No. SC154) purchased from DKSH 118 
Pty. Ltd. Australia. 119 
All reagent additions and dilutions were carried out using a semi – automated Gilson 120 
402 diluter (John Morris Scientific, Keswick, South Australia). The dilutor tubing (FEP 121 
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– Fluorinated ethylene propylene) was soaked in 8% TMAH overnight and thoroughly 122 
rinsed with high purity water before use.  123 
Pure water was dispensed with a Brand® bottle top dispenser (5–50 mL Dispensette® 124 
Organic, Digital Cat. No. 4730 360) 125 
The TMAH powder and all containers and equipment used to prepare the samples or 126 
store/collect the breast milk were checked for iodine contamination before use. 127 
 128 
Reagents and Standard Solution Preparation 129 
To prepare the 25% TMAH and 8% TMAH solutions, 125 g or 40 g respectively of 130 
TMAH was dissolved in high purity water and made up to 500 mL. These solutions 131 
were stored at room temperature. 132 
Internal standard stock solutions. 1.6 mL of Te stock standard, 2 mL of Sb stock 133 
standard and 40 mL of 25% TMAH were diluted in high purity water to a final volume 134 
of 1000 mL to make solutions of 1.6 mg L
-1
 Te and 2 mg L
-1
 Sb which were stored at 135 
room temperature. These solutions were further diluted during the calibration standard 136 
preparation and digestion process to yield 40 µg L
-1
 Te and 50 µg L
-1
 Sb in the final 137 
analyzed solutions. 138 
Iodide spiked solutions. To prepare iodide spiked solutions, the 1000 mg L
-1
 iodide 139 
stock solution was diluted with high purity water to yield 50 mg L
-1
 iodide solution. 140 
This solution was further diluted in 1% TMAH to produce final concentrations of 0.2, 141 
0.4 and 0.8 mg L
-1
. These solutions in turn were used as spiked solutions in recovery 142 
tests, producing concentrations of 2.5, 5.0 and 10 µg L
-1
 in the final analyzed samples 143 
Thyroxine spiked solutions. To prepare thyroxine (T4) spiked solutions, 0.1531 g of T4 144 
was dissolved in 20 mL of 25% TMAH and diluted to 2 L with high purity water to 145 
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yield a 50 mg L
-1
 T4 iodine solution in 1% TMAH. This solution was further diluted in 146 
1% TMAH to produce final concentrations of 0.2, 0.4 and 0.8 mg L
-1
. These solutions 147 
in turn were used as spiked solutions for recovery tests producing concentrations of  2.5, 148 
5.0 and 10 µg L
-1
 T4 in the final analyzed samples. 149 
Iodine calibration solutions (0, 1, 2.5, 5, 10, 25, 50, 100 and 200 µg L
-1
). The iodine 150 
stock solution (1000 mg L
-1
) was diluted in high purity water to a concentration of 5 mg 151 
L
-1
 (intermediate stock standard). This solution was further diluted to prepare 152 
intermediate standard 1 and 2 with concentrations of 1.0 and 0.05 mg L
-1
 respectively 153 
and these 2 standards in turn were used to make the calibration solutions in 1% TMAH. 154 
1 mL of internal standard solution was added to 40 mL of each these iodine calibration 155 
solutions. The calibration solutions were stored at room temperature and fresh solutions 156 
prepared every 4 months. 157 
Iodine drift correction standard solutions (0 and 5 µg L
-1
). The iodine intermediate 158 
standard 2 solution (0.05 mg L
-1
) was used to make the drift correction standard. Both 159 
these standards were prepared in 1% TMAH. 1 mL of internal standard solution was 160 
added into 40 mL of each these iodine drift correction standard solutions. 161 
Blanks. Four types of blanks were used; a calibration blank, a method digestion blank 162 
processed in exactly the same way as the samples and containing all the reagents used in 163 
the assay, a drift correction blank and a system blank. All blanks were prepared in 1% 164 
TMAH and also contained the internal standard mix. The calibration blank was used to 165 
establish the analytical calibration curve, the method digestion blank was used to 166 
account for batch to batch variation and to overcome system memory effects from the 167 
instrument by subtraction during result calculation, the drift correction blank was used 168 
to normalize the drift standard solution every 25 samples during each analytical run and 169 
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the system blank was used to monitor the overall system memory from the instrument 170 
during each analytical run. 171 
Wash solutions. Three types of wash solutions were used.  Two of the solutions, the 172 
auto-sampler wash station rinse solution and an extra clean wash solution, consisted of 173 
1% TMAH and high purity water. Another pre – wash solution was prepared with 1% 174 
ammonia (NH4) in high purity water.  175 
 176 
Instrumentation 177 
Iodine determination was carried out using an Agilent7500ce ICPMS system consisting 178 
of an Integrated Sample Introduction System (ISIS) unit plus a CETAC ASX-510 auto-179 
sampler (Agilent Technologies Australia) equipped with a Ceramic VeeSpray nebulizer 180 
(Glass Expansion Pty. Ltd, Melbourne, Australia). The ISIS peristaltic pump program 181 
was used to reduce the washout time and speed up sample uptake to the instrument 182 
between samples to reduce analysis time per sample. Instrument performance 183 
optimization, including nebulizer gas flow rate, ion lens voltage and torch alignment, 184 
was set up following the manufacturer’s instructions and optimized before each run. 185 
Operating conditions for the systems are shown in Table 1. 186 
All raw concentration data from the ICPMS was exported to Microsoft Excel. Blank 187 
subtraction, drift correction and other data processing (mass and volume adjustments) 188 







Sample Digestion 194 
1 mL of homogenized breast milk measured using the Gilson 402 diluter or 0.1 g of 195 
milk powder was placed into labeled 50 mL PP tubes, 5 mL of 8% TMAH plus 0.75 mL 196 
of pure water was then added to each of the tubes using the diluter and the tubes 197 
recapped. Samples were mixed by shaking/vortexing at low speed and allowed to stand 198 
overnight in a fumehood at room temperature. On the following day, samples were 199 
mixed again by shaking/vortexing and digested at 90
0
C for 1 hour using the heating 200 
block system. Samples were mixed by shaking/vortexing at least twice during the 201 
incubation period to ensure complete digestion. The tubes were then removed from the 202 
heating block and cooled at room temperature. 1 mL of internal standard solution plus 203 
2.25 mL of pure water was added to all tubes using the diluter and the volume made up 204 
to 40 mL by the addition of 30 mL high purity water using a Brand® bottle top 205 
dispenser. The tubes were tightly recapped, shaken/vortexed until thoroughly mixed and 206 
then 5 – 10 mL of each digested solution was filtered and transferred into graduated 15 207 
mL PP tubes prior to ICPMS analysis.  208 
 209 
Method Optimization 210 
Optimal digestion time and temperature for iodine (iodide and T4) extraction from 211 
human breast milk 212 
The efficiency of iodine extraction from breast milk and NIST 1549 milk powder by 213 
TMAH was tested under 3 different conditions: (1) 80
0
C for 1 hour, (2) 90
0
C for 1 hour 214 
and (3) 90
0
C for 2.5 hours. The recovery of iodine from the NIST 1549 milk powder 215 




Instrument/system memory effect  218 
Depending on the prior use of the ICPMS instrument (nitric acid digests or TMAH 219 
digestions) the system showed various levels of iodine contamination. The most 220 
effective pre – wash solution was determined by comparing the time taken for the 221 
background count to decrease to an acceptable and stable level (600 - 1000 222 
counts/second for iodine) following a continuous pre – wash with 1% TMAH or 1% 223 
ammonia. 224 
The efficiency of cleaning up the ICPMS system with the 1% TMAH pre – wash 225 
solution was tested for 3 levels of iodine contamination, namely highly contaminated 226 
(0.46µg L
-1
), slightly contaminated (0.3µg L
-1
) and a clean system (0.06µg L
-1
). The 227 
cleaning efficiency of the 1% NH4 pre – wash solution was also tested on a highly 228 
contaminated system. Furthermore, the clean – up efficiency of the pre – wash solution 229 
was monitored in each analytical run by collecting iodine concentrations of all the blank 230 
solutions defined above to assess the instrument memory effect. 231 
Sample – to – sample carryover 232 
Previous studies in our group had indicated that 4 % perchloric acid digests and high 233 
salt matrices had the potential to cause precipitation within a range of nebulizers leading 234 
to significant drift throughout long analytical runs. These studies also suggested the use 235 
of wet argon in the nebulization gas could prevent significant drift and reduce sample – 236 
to – sample carry over. In the present study, sample carryover from a previous analytical 237 
sample was determined after washing the nebulizer with either dry or wet argon. 238 
The sample carryover in these tests was determined by assessing iodine concentration in 239 
15 successive replicate blanks following the measurement of iodine in a highly 240 
concentrated standard solution (200 µg L
-1
).  241 
11 
 
Stability of the iodine calibration standards 242 
Three of the iodine standard solutions (2.5, 5 and 10µg L
-1
) were analyzed on repeated 243 
occasions over a 2.5 month period to assess the stability of iodine standards during 244 
storage. The iodine concentrations measured at each of the time points across the 2.5 245 
month period were compared to those in the equivalent standard immediately after 246 
preparation. 247 
 248 
Stability and reliability of internal standards 249 
The stability and reliability of two internal standards, Sb and Te, were tested in the 250 
human breast milk matrix in order to assess their suitability for routine analysis. Human 251 
breast milk samples, NIST non – fat milk powder reference material and standards were 252 
prepared as described earlier with the addition of a mixture of 2 internal standards (Sb 253 
and Te).  The raw counts of iodine (I), Sb and Te were monitored to check for stability. 254 
The raw I counts were also normalized to both the raw Sb and Te counts to evaluate the 255 
stability and reliability of each internal standard across the analytical run. 256 
Human breast milk homogeneity  257 
After collection, the breast milk sample was mixed by shaking vigorously, split into 2 258 
aliquots and then frozen at -20°C until analysis. After thawing, one aliquot was 259 
homogenized at 20,000 min
-1 
for 30 seconds  while in the other the milk was allow to 260 
separate into two phases, the aqueous and fatty fractions. The iodine level of each 261 






Stability of extracted samples  266 
To assess the stability of iodine in samples post – digestion, NIST 1549 milk powder 267 
and 2 human milk samples were digested by using the digestion procedure described 268 
above and iodine levels measured on the day of digestion and following 2.5 months 269 
storage at room temperature.  270 
Contamination check of components used in the milk collection and analysis  271 
A small amount of high purity water was placed into the various containers and devices 272 
used in the milk collection process. This included 2 types of collection containers, 2 273 
types of breast pump systems and 2 types of storage tubes.  The water was left to 274 
stabilize for periods varying from 3 hours to 2.5 weeks. Samples of this high purity 275 
water were then collected and tested for iodine contamination using the same method as 276 
for human milk samples. The contamination check was also conducted for all the 277 
disposable PP tubes used in the digestion and analysis steps. 278 
 279 
Method Validation 280 
Linearity  281 
The iodine standards (0, 1, 2.5, 5, 10, 25, 50, 100, 200 µg L
-1
) were used to establish the 282 
calibration curve. In order to ensure accuracy, the iodine concentrations of all samples 283 
analyzed are required to fall within the range of the calibration curve, otherwise the 284 
samples need to be diluted.  285 
Recovery 286 
A breast milk sample, NIST 1549 milk powder and a method digestion blank were used 287 
to determine the percent recovery of various levels of added iodine in the samples. The 288 
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breast milk and milk powder samples were spiked with 5 and 10 µg L
-1 
of iodide 289 
solution and also with 5µg L
-1
 and 10 µg L
-1
 of T4 iodide solution. The method 290 
digestion blank was spiked with 2.5 and 5.0 µg L
-1
 of iodide solution and also with 291 
2.5µg L
-1
 and 5.0 µg L
-1
 of T4 iodide solution. The unspiked samples and all spiked 292 
samples were measured in quadruplicate. The measured iodine concentration was 293 
divided by the expected value in order to determine the percent recovery. 294 
Precision  295 
The intra – assay and inter – assay variation were determined by analyzing 2 breast milk 296 
samples and NIST 1549 milk powder either 4 times in a single run (intra – assay 297 
coefficient of variation) or on 4 different days in 4 separate assays (inter – assay 298 
coefficient of variation). 299 
Accuracy  300 
The method was validated for accuracy by comparing the iodine concentration obtained 301 
for 78 replicates of NIST CRM 1549 milk powder analysis carried out over a period of 302 
~ 3 years. The % relative standard deviation (%RSD) of repeatability and 95 % 303 
confidence interval (CI) were calculated. 304 
Limit of Detection (LOD) and Method Quantitation Limit (MQL) 305 
LOD refers to the lowest concentration where we can just distinguish a signal from the 306 
background. For this publication we used the definition of the limit of detection set by 307 
the International Union of Pure and Applied Chemistry (IUPAC) [18] and the National 308 
Association of Testing Authorities, Australia (NATA) [19]   309 
According to this definition, LOD was calculated as the mean concentration plus 3 X 310 
the standard deviation of the concentration of a calibration blank measured in the same 311 
assay at least 7 times.  312 
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The MQL is defined as the minimum concentration of an analyte that can be measured 313 
within specified limits of precision and accuracy and is calculated as 3 X LOD 314 
multiplied by the dilution factor. This takes into account any matrix related effects. 315 
Instrument Detection Limit (IDL) is equivalent to the LOD in our case. The Instrument 316 
Quantitation Limit (IQL) is calculated as 3 X LOD. 317 
 318 
RESULTS 319 
Method Optimization 320 
Optimal digestion time and temperature for iodine extraction from human breast milk  321 
It was critical to achieve a complete sample digestion to ensure the accuracy of iodine 322 
measurements conducted in downstream applications, including ICPMS. As illustrated 323 
in Table 2 the efficiency of extraction of iodine from human breast milk was similar 324 
under all tested conditions. The extraction efficiency for the NIST CRM 1549 milk 325 
powder also showed good agreement with the certified value (3.38±0.02 mg kg
-1
) for all 326 
3 processes tested. We chose to use a digestion temperature of 90
0
C for 1 hour for all 327 
subsequent experiments to reduce the overall time required for sample preparation. 328 
Instrument/system memory effect  329 
We found 2 significant areas within the ICPMS that showed memory effect; the auto-330 
sampler wash station and the uptake tubing/nebuliser/spray chamber area. There was a 331 
marked difference in the time taken for the background counts to drop to acceptable 332 
levels between the 1% TMAH and 1% NH4 pre – wash solutions. When using 1% 333 
TMAH to wash out the the 2 areas identified above, the background count levels 334 
decreased gradually and often did not reach an acceptable level even after ~ 2 - 3 hours 335 
from the start of the wash procedure or well into the actual analysis run. In contrast, 336 
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using a 1% NH4 solution resulted in a sharp drop in the background counts to an 337 
acceptable level after only 10 minutes in the uptake area. The auto – sampler wash 338 
station also required extra soaking with 1% NH4 to remove long term buildup (data not 339 
shown).   340 
The data presented in Figure 1 supports these findings. . In the clean system, achieved 341 
after 1 day of running routine breast milk iodine analyses, the iodine concentration in 342 
the blank decreased only slightly at the start of the run before stabilizing, indicating that 343 
there was minimal iodine contamination prior to the start of the run. In contrast, in both 344 
the highly contaminated and slightly contaminated systems, the iodine concentrations in 345 
the blank solutions analyzed after the pre-wash with 1% TMAH dropped sharply at the 346 
beginning of the analysis run before declining to acceptable iodine levels for the blank 347 
sample, indicating that 1% TMAH wash – out was not effective at reducing the iodine 348 
concentrations to acceptable levels prior to the analytical run. In the highly 349 
contaminated system cleaned using the 1% NH4 pre – wash solution, however, we 350 
achieved a similar washout profile to the clean system washed with 1% TMAH. This 351 
suggested that a 1% NH4 pre – wash solution could be used once before each run to 352 
achieve an acceptable background count at the beginning of the analytical run.  353 
We also observed a substantial and variable drop in the baseline counts depending upon 354 
the extent of the system contamination, indicating that the way the method digestion 355 
blank is handled is critical with respect to the calculation of the final results. We 356 
therefore subtracted our method digestion blank value from each batch of samples as a 357 
part of calculation. 358 
Sample – to – sample carryover 359 
Figure 2 shows the result of the sample carryover experiment comparing the extent of 360 
carryover after using either wet or dry argon to rinse the nebulizer between samples. 361 
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There was no significant difference in the reduction of carry over effects between the 362 
wet and dry argon in this system.  363 
Stability of the iodine calibration standards 364 
Over the 2.5 month period, the percentage error for the measurement of the 3 iodine 365 
calibration solutions ranged from -1.3 to +0.5% with respect to their actual 366 
concentration. Iodine standard solutions appeared to be very stable after preparation for 367 
a period of at least 6 months (data not shown). 368 
Stability and reliability of internal standards  369 
As expected with ICPMS the raw count stability over the various runs varied 370 
significantly for both internal standards as well as iodine (data not shown). When the 371 
raw iodine counts were normalized to the raw counts for the 2 internal standards in the 372 
drift check standard, the stability for iodine concentration measured across the run 373 
improved significantly for both Sb and Te. When Sb was used the internal standard, the 374 
values for the NIST milk powder certified reference material were consistent with the 375 
expected value. However, when the iodine counts were normalized to the Te standard 376 
counts, the calculated result for the NIST milk powder certified reference material 377 
exceeded the expected value by 10% of the expected value. Sb was therefore selected as 378 
the internal standard used to correct for the variability caused by matrix effects and 379 
instrument drift in this assay. 380 
Human breast milk homogeneity 381 
The iodine level in the fatty fraction (145 ± 48 µg L
-1
) was considerably higher and 382 
more variable than in the aqueous fraction (88.5 ± 2.1 µg L
-1
). The iodine concentration 383 
in the homogenized samples (105.7 ± 0.6 µg L
-1
) were notably less variable, and were 384 
intermediate to that of the two separate fractions. These iodine concentrations were 385 
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within the expected range of breast milk iodine levels in breast-feeding women from 386 
iodine sufficient populations(unpublished data). 387 
Stability of extracted samples 388 
There was no difference in the iodine concentration measured in digested samples 389 
immediately after digestion or after 2.5 months of storage post-digestion (Table 3). 390 
Contamination check of components used in milk collection and analysis.  391 
No iodine contamination was detected in any of the equipment used to collect and 392 
analyze human milk. All results were below the MQL (1.6 µg L
-1
) for all tested 393 
components. 394 
 395 
Method Validation  396 
Linearity 397 
The standard curve was linear up to 200µg L
-1
 iodine and the slope and coefficient of 398 
correlation were 0.0162 and 0.9999 respectively.  399 
Recovery  400 
For the NIST SRM (n=4), recoveries between 95.5 % and 96.5 % were achieved for 401 
solution spiked with both low (5µg L
-1
) and high (10 µg L
-1
) amounts of iodine (Table 402 
4). For human breast milk samples, the percentage recovery of iodine from all the 403 
spiked samples was between 96.5 % and 97.2 % (n=4 for each spiked concentration 404 
level). A recovery of ~ 96 % also found in breast milk samples and NIST milk powder 405 
spiked with the 2 different concentrations of T4. The percentage recoveries for all T4-406 




The intra – assay CoVs for iodine concentration of 2 breast milk samples were 0.1% 409 
and 1.8%, respectively whilst NIST 1549 milk powder were 0.97 %. The inter – assay 410 
CoVs were 2.2%, 3.06% and 0.25 %, respectively 411 
 412 
Accuracy 413 
The results obtained for the NIST milk standard using this method was 3.38 ± 0.02 mg 414 
kg
-1
 (N = 78) was in a close agreement with the certified value of 3.38 ± 0.02mg kg
-1
. 415 
The RSD was 0.5 % with a 95 % CI of 0.005. 416 
Detection limits  417 
The IDL for iodine in human milk was 0.013 µg L
-1
 if carryover and contamination 418 
were eliminated as described in this paper. Assuming a dilution factor of 40, the MQL 419 
was 1.6 µg L
-1
.  420 
 421 
DISCUSSION 422 
This paper describes the development and validation of a method for the assessment of 423 
iodine concentration in human breast milk which offers significant improvements over 424 
existing methods in relation to detection/quantitation limit, choice of internal standard 425 
and minimization of instrumental memory effect during analysis.  426 
 427 
The performance of the method was evaluated with respect to linearity, recovery, 428 
precision, accuracy and quantitation limit. The method exhibited strong linearity (R
2
 > 429 
0.999 and slope of 0.0162) and achieved high recovery (> 94%) of iodine from milk 430 
samples spiked with either iodine or T4. The intra – and inter – assay coefficients of 431 
variation of the  breast milk and NIST milk powder samples were both <3.5% and the 432 
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iodine level measured in NIST 1549 milk powder using this method were in close 433 
agreement with the certified value, indicating a high degree of reliability and precision. 434 
The quantitation limit for this method of 1.6µg L
-1
, was much lower than the 435 
quantitation limits which have been reported in previous methods, which have ranged 436 
from 14 – 30µg L-1 [3,13,14,20]. Importantly, the quantitation limit we achieved in our 437 
method is also well below the expected range of iodine concentrations in human breast 438 
milk, even in regions classified as iodine deficient (32 – 78µg L-1) [21-23], suggesting 439 
that the method is appropriate for the assessment of iodine concentrations in breast milk 440 
across a broad range of populations. 441 
 442 
Sample digestion is a critical step in ensuring accurate determination of the iodine 443 
content of samples by ICPMS, and establishing a method for the digestion of human 444 
milk samples which did not affect iodine concentrations in the sample was a critical 445 
component of this study. Previous studies had shown that extraction by acidic and 446 
ammonia media had the potential to affect the accuracy of the analysis, by inducing 447 
instrument memory effects [24] and variations in the efficiency of iodine extraction 448 
between samples [25,26]. As a result, we chose to use another widely applied digestion 449 
medium, TMAH, in this method. The use of TMAH in iodine extraction for ICPMS 450 
analysis has previously been applied to infant formula [9], milk powder [9,13,16,27] 451 
and herb milk [28], but this is the first report of its successful application in the 452 
assessment of iodine in human breast milk samples. In addition, we showed that we 453 
were able to obtain complete and reproducible digestion with considerably shorter 454 
heating times compared to previous studies (1 hour vs 2-3 hours) [7,13,16] thus 455 




Although previous studies have suggested that iodine species in biological samples can 458 
be extracted by TMAH, there had been no reports of successful extraction of iodine 459 
from iodine – containing compounds, such as T4. The failure to liberate iodine from 460 
such compounds during the digestion process would result in underestimation of the 461 
iodine content of the sample, thus impacting on accuracy and reliability of the 462 
measurements. By assessing the recovery of iodine from human breast milk samples 463 
spiked with T4 in the present study, we confirmed that TMAH digestion was able to 464 
release iodine from this complex, and therefore provide an accurate measure of the total 465 
iodine content of the sample.  466 
 467 
 We did not find any difference between wet and dry argon in the efficacy of reducing 468 
carryover between samples in this study. Although not the focus of our study, flushing 469 
the system with wet argon is likely to be preferable in practice, since it is able to prevent 470 
the build of iodine contamination within the argon jet in the nebulizer, which has the 471 
potential to introduce random errors during large analytical runs (unpublished data). We 472 
identified the auto – sampler wash station as a major source of instrument carryover 473 
when the ICPMS machine had previously been utilized for the assessment of other 474 
elements and using other wash out solutions (e.g. nitric acid solutions). Thus, 475 
thoroughly flushing the system with a 1% NH4 solution prior to commencing any new 476 
assay is necessary to avoid carryover effects due to previous analyses conducted on the 477 
same instrument. 478 
 479 
Drift is an analytical error leading to the poor accuracy, and arises when instrument 480 
responses change through the run. The drift can be corrected by analyzing drift 481 
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standards after every four to five samples [29], however no previous studies involving 482 
assessment of iodine content in breast milk have included an approach for drift 483 
correction. Instrument performance in this method was monitored by including a high 484 
drift standard (5 µg L
-1
) and drift correction blank (0µg L
-1
) after every 25 samples, and 485 
we were able to use this to appropriately correct for the drift in the experimental 486 
procedure. Measurement of drift standards after 25 samples, instead of 4 – 5 samples 487 
reduces the cost and reading time in routine analysis. It was also noted that the largest 488 
difference between successive drift iodine levels occurred at the beginning of the run 489 
and this also needed to be taken into account during the drift correction to achieve the 490 
most accurate results.  491 
 492 
Te has commonly been used as an internal standard in ICPMS methods and was 493 
selected due to the fact that its ionization status is closer to iodine than other elements 494 
[13]. However, the Te signal in the milk powder experiment was lower and more 495 
variable than expected, resulting in reduced accuracy in the assessment of iodine 496 
concentrations. This may be because Te precipitates with some components within the 497 
human milk matrix, and indicates that it is not the most appropriate internal standard for 498 
this method. However, Sb exhibited much greater stability in the human milk matrix in 499 
the present study and appears to be a more suitable internal standard for ICPMS 500 
assessment of human breast milk.  501 
 502 
In a previous study reporting the analysis of iodine in food, high-cost tubes were used 503 
during sample digestion, which were washed and re-used for subsequent assays. Even 504 
with thorough washing, there is the potential for trace amounts of iodine to remain in 505 
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the tubes, which could produce carryover effects and introduce inaccuracies in the 506 
results [13]. In this method, we eliminated this source of contamination by using 507 
disposal screw cap polypropylene tubes [30]. Disposable auto – sampler tubes and 508 
pipette tips were also used to minimize the potential for contamination. Importantly, we 509 
confirmed that all the containers and equipment that were in contact with the sample at 510 
any stage in the process of collection, processing and analysis were free from iodine 511 
contamination, and can thus be confident that any iodine detected in this assay 512 
originated from the breast milk sample. Confirming the absence of contamination is 513 
critical to ensuring that the results of the assay are a true reflection of concentrations in 514 
the sample and should be standard practice in any application of this method.  515 
 516 
Appropriate sample preparation is essential to achieve reliable results. Despite the fact 517 
that human milk is known to separate into 2 distinct layers after thawing or during 518 
extended periods of standing, no previous method has provided detailed information 519 
regarding sample preparation. This study confirmed that iodine concentration differs 520 
markedly between the fatty and aqueous fractions of human milk and that complete 521 
homogenization of the samples is required prior to digestion in order to obtain reliable 522 
results.  523 
The stability of extracted human milk samples had not been tested in previous methods. 524 
In this modified method we found that iodine level in extracted human milk also 525 
containing the internal standard was stable for at least 2.5 months when stored at room 526 
temperature. The finding increases the potential for this method to be utilized in large-527 
scale clinical trials and population screening programs, since it makes it possible for 528 




In conclusion, we have successfully validated a method for the assessment of iodine in 531 
human breast milk which overcomes the limitations of previous approaches and highly 532 
accurate, reproducible and precise. The modified method is able to recover over 95% of 533 
iodine from spiked solutions, has a lower quantitation limit than previous method and 534 
has inter – and intra – assay coefficients of variation well below 5%. This method 535 
represents a significant advance in the assessment of iodine concentrations in human 536 
breast milk and its application will enable us to gain new insights into the iodine status 537 
of lactating women. This assay is currently being applied for routine assessment of 538 
iodine concentration in breast milk samples in our laboratory. 539 
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Figure 1: Instrument/system memory effect: Iodine concentration of the drift correction 647 
blank (0µg L
-1
) over the course of an ICPMS run at 3 levels of system contamination; 648 
Contaminated system after 1% TMAH pre – wash solution ( ), slightly contaminated 649 
system after 1% TMAH pre – wash solution ( ) and clean system after 1% TMAH pre 650 
– wash solution ( ), contaminated system after 1% NH4 pre – wash solution ( ). 651 
The iodine concentration at t=0 represents the iodine calibration blank concentration. 652 
The negative iodine concentrations indicate the extent of wash – out during each 653 
analytical run.  654 
Figure 2: Sample-to-sample carryover: iodine washout with dry argon (─) and wet (---) 655 
argon after analyzing 200 µg L
-1
 iodide. IQL, instrument quantitative limit; IDL, 656 
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Table 1: Agilent ICPMS operating conditions 686 
RF power (W) 1500 
RF matching (W) 1.66 
Frequency (MHz, free running) 27 
Sampling depth (mm) 0.8 
Carrier gas (L/min) 1.00 
Makeup gas (L/min) 0.20 
Nebulizer Ceramic VeeSpray 
Spray chamber Double Pass 
Nebulizer pump (rps) 0.20 
Lens Settings Optimized with each run 
Iodine (I) - Mass 127 
Antimony (Sb) - Mass 121 
Tellurium (Te) - Mass 128 
Scanning mode Peak hoping 
Points / peak 3 
Number of replicates 3 
 687 
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Table 2: Comparison of iodine concentration determined in the sample NIST 1549 milk 689 
powder and human breast milk samples for each of the 3 digestion conditions 690 
Materials 80
0
C / 2.5h 90
0
C / 1h 90
0
C / 2.5h 
NIST 1549 milk powder (mg kg
-1
) 
(N = 3) 
3.39 ± 0.03 3.37 ± 0.01 3.38 ± 0.01 
Human milk 1 (µg L
-1
) 
(N = 2) 
88.7 ± 0.5 89.7 ± 2.8 88.0 ± 0.02 
Human milk 2 (µg L
-1
) 
(N = 2) 
74.3 ± 0.2 74.2 ± 0.1 74.4 ± 0.06 

















Table 3: The stability of extracted samples 706 
Materials 0 month 2.5 months 
NIST 1549 milk powder (mg kg
-1
) 
(N = 2) 
3.39 ± 0.01 3.39 ± 0.01 
Human milk 1 (µg L
-1
) 
(N = 3) 
106 ± 1.0 105 ± 1.0 
Human milk 2 (µg L
-1
) 
(N = 4) 
79.8 ± 1.7 81.0 ± 1.4 

















Table 4: Iodine recovery percentage for samples spiked with iodide and T4. 722 
Sample 
Iodine concentration T4 concentration 
2.5 µg L
-1
 5 µg L
-1




 5.0 µg L
-1
 10 µg L
-1
 
Blank 93.8 ±0.5 97.2±0.5 - 96.2±0.5 98.2±0.5 - 
NIST milk powder - 96.0±1.6 95.5±0.8 - 96.0±1.6 96.5±1.3 
Breast milk  - 97.2±0.5 96.5±0.6 - 96.5±1.3 96.8±1.0 
Values expressed as mean % ± SD. (N = 4) 723 
 724 
